Advertisement
News
Advertisement

ImmunoGen loses value after reporting greater Q1 loss

Fri, 10/26/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

ImmunoGen Inc. lost much of the stock value it had gained over the summer (due to positive news from its potential drug for breast cancer) after announcing Friday morning that its most recently quarterly loss is 29 percent greater than last year.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading